drugset / Trial / NCT00246168

ULTRACET (Tramadol Hydrochloride and Acetaminophen) for the Treatment of Rheumatoid Arthritis Pain.

NCT00246168

Phase 4 Completed 277 enrolled Janssen Korea, Ltd., Korea
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the effectiveness of ULTRACET® (a combination analgesic) as add-on therapy in rheumatoid arthritis patients taking an NSAID (e.g. Advil®, Motrin® or other nonsteroidal anti-inflammatory drug) or a COX-2 inhibitor (e.g. Celebrex®).

Timeline

Start
Primary completion
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 325 mg Oral
Subject Tramadol Other / unclassified 37.5 mg Oral

Indications